By Dr. Eugene Huang
A new study published in the Lancet Oncology this year showed that stereotactic radiation could be an equally effective option instead of surgery for patients with early-stage lung cancer. This pooled analysis of two randomized clinical trials comparing surgery versus stereotactic radiation showed that both treatment options had equally good survival and tumor control rates of over 80%. Patients treated with stereotactic radiation tolerated treatment better with fewer side effects.
Cyberknife is the most advanced and precise technology available today to deliver stereotactic radiation. Alaska Cyberknife Center is proud to offer this treatment to the residents of Alaska.
Click here to view the full study.